Publications by authors named "Colt A Egelston"

Claim this Profile
D
Divergent oncogenic signaling and immune microenvironment changes in low-grade serous ovarian cancer patients undergoing intraperitoneal chemotherapy.
Isaac Bishara, Patrick A Cosgrove, Sumana Majumdar, Colt A Egelston, Oscar Colunga Flores

NPJ Precis Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Organ-Specific Immune Setpoints Underlie Divergent Immune Profiles across Metastatic Sites in Breast Cancer.
Colt A Egelston, Weihua Guo, Diana L Simons, Jian Ye, Christian Avalos

Cancer Immunol Res· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor draining lymph nodes connected to cold triple-negative breast cancers are characterized by Th2-associated microenvironment.
Weihua Guo, Jiayi Tan, Lei Wang, Colt A Egelston, Diana L Simons

Nat Commun· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
STING signalling compensates for low tumour mutation burden to drive anti-tumour immunity.
Jiayi Tan, Colt A Egelston, Weihua Guo, Jeremy M Stark, Peter P Lee

EBioMedicine· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor heterogeneity and clinically invisible micrometastases in metastatic breast cancer-a call for enhanced surveillance strategies.
Eliza R Bacon, Kena Ihle, Weihua Guo, Colt A Egelston, Diana L Simons

NPJ Precis Oncol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peritumoral Immune-suppressive Mechanisms Impede Intratumoral Lymphocyte Infiltration into Colorectal Cancer Liver versus Lung Metastases.
Jian Ye, Weihua Guo, Chongkai Wang, Colt A Egelston, Massimo D'Apuzzo

Cancer Res Commun· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and efficacy of pembrolizumab and doxorubicin in a phase I trial for patients with metastatic triple-negative breast cancer.
Colt A Egelston, Weihua Guo, Susan E Yost, Xuan Ge, Jin Sun Lee

Cancer Immunol Immunother· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic Markers of CDK 4/6 Inhibitor Resistance in Hormone Receptor Positive Metastatic Breast Cancer.
Jin Sun Lee, Susan E Yost, Sierra Min Li, Yujie Cui, Paul H Frankel, Colt A Egelston

Cancers (Basel)· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-infiltrating exhausted CD8+ T cells dictate reduced survival in premenopausal estrogen receptor-positive breast cancer.
Colt A Egelston, Weihua Guo, Jiayi Tan, Christian Avalos, Diana L Simons

JCI Insight· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I/II trial of palbociclib, pembrolizumab and letrozole in patients with hormone receptor-positive metastatic breast cancer.
Yuan Yuan, Jin Sun Lee, Susan E Yost, Paul H Frankel, Christopher Ruel, Colt A Egelston

Eur J Cancer· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mature Dendritic Cells May Promote High-Avidity Tuning of Vaccine T Cell Responses.
Adarsh Kumbhari, Colt A Egelston, Peter P Lee, Peter S Kim

Front Immunol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase II Clinical Trial of Pembrolizumab and Enobosarm in Patients with Androgen Receptor-Positive Metastatic Triple-Negative Breast Cancer.
Yuan Yuan, Jin Sun Lee, Susan E Yost, Paul H Frankel, Christopher Ruel, Colt A Egelston

Oncologist· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Pilot Feasibility Study of Yttrium-90 Liver Radioembolization Followed by Durvalumab and Tremelimumab in Patients with Microsatellite Stable Colorectal Cancer Liver Metastases.
Chongkai Wang, John Park, Ching Ouyang, Jeff A Longmate, Michael Tajon, Colt A Egelston

Oncologist· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Deficiency Leads to Decreased Numbers of Peripheral Blood B Cells and Defective Germinal Center Reactions.
Silke E Lindner, Colt A Egelston, Stephanie M Huard, Peter P Lee, Leo D Wang

Immunohorizons· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resident memory CD8+ T cells within cancer islands mediate survival in breast cancer patients.
Colt A Egelston, Christian Avalos, Travis Y Tu, Anthony Rosario, Roger Wang

JCI Insight· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic Checkpoint of Immune Cells in Melanoma Brain Metastases.
Colt A Egelston, Kim Margolin

Cancer Discov· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synchronous recurrence of concurrent colon adenocarcinoma and dedifferentiated liposarcoma.
Eric E Jung, F Scott Heinemann, Colt A Egelston, Jennifer Wang, Raphael E Pollock

BMJ Case Rep· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human breast tumor-infiltrating CD8 T cells retain polyfunctionality despite PD-1 expression.
Colt A Egelston, Christian Avalos, Travis Y Tu, Diana L Simons, Grecia Jimenez

Nat Commun· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of shared TCR sequences from T cells in human breast cancer using emulsion RT-PCR.
Daniel J Munson, Colt A Egelston, Kami E Chiotti, Zuly E Parra, Tullia C Bruno

Proc Natl Acad Sci U S A· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis